Close this search box.

Company Name: MyoKardia, Inc.

MyoKardia, Inc. is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of precision medicines designed to treat rare cardiovascular diseases. The company’s initial focus is on developing therapies designed to treat hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM).

Ticker Symbol: MYOK (NASDAQ)

Company Website:

Social Media:

MyoKardia LinkedIn

MyoKardia Twitter

Classification: Biotech

Areas of Focus:


Rare Diseases


Headquarters: South San Francisco, CA

Related Links:

List of Healthcare Companies

List of Pharmaceutical Companies

Publicly Traded Companies in California

Publicly Traded Companies by Sector and Industry

Large-Cap Biotech Stocks

Mid-Cap Biotech Stocks

Small-Cap Biotech Stocks

Micro-Cap Biotech Stocks

Nano-Cap Biotech Stocks